• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性中心性浆液性脉络膜视网膜病变:长期随访及与视力相关的生活质量

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life.

作者信息

Breukink Myrte B, Dingemans Alexander Jm, den Hollander Anneke I, Keunen Jan Ee, MacLaren Robert E, Fauser Sascha, Querques Giuseppe, Hoyng Carel B, Downes Susan M, Boon Camiel Jf

机构信息

Department of Ophthalmology.

Department of Ophthalmology; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

Clin Ophthalmol. 2016 Dec 20;11:39-46. doi: 10.2147/OPTH.S115685. eCollection 2017.

DOI:10.2147/OPTH.S115685
PMID:28053499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5189979/
Abstract

PURPOSE

To describe the clinical findings and long-term outcome of patients with chronic central serous chorioretinopathy (cCSC).

MATERIALS AND METHODS

This was a retrospective case series in 52 eyes of 36 patients with a follow-up period of at least 1 year. Extensive ophthalmic examination and a validated questionnaire concerning vision-related quality of life (National Eye Institute Visual Function Questionnaire [NEI-VFQ]-39) were analyzed.

RESULTS

Mean visual acuity showed a significant decline over time of 0.16 logarithm of minimum angle of resolution ([logMAR] range: -0.22 to 1.3; =0.009) after a mean follow-up period of 10.6 years. Also, patients reported lower vision-related quality of life based on the NEI-VFQ-39 for almost all categories compared to healthy controls. Macular atrophy was diagnosed more often on optical coherence tomography compared to other diagnostic entities. Retinal pigment epithelium detachments in the macula were documented on optical coherence tomography in 56% of the patients. A significant thinning of foveal thickness was measured over time compared to unaffected fellow eyes (=0.002). On long-term follow-up, 13 eyes (37%) showed an increase in number of hot spots on fluorescein angiography.

CONCLUSION

This study indicates that cCSC is a progressive disease in many patients, causing a progressive decline in visual acuity, accompanied by lower reported vision-related quality of life. In deciding whether or not to treat, the progressive nature of cCSC should be taken into account in this relatively young and often still professionally active patient group.

摘要

目的

描述慢性中心性浆液性脉络膜视网膜病变(cCSC)患者的临床特征及长期预后。

材料与方法

这是一项回顾性病例系列研究,纳入36例患者的52只眼,随访期至少1年。分析了全面的眼科检查结果以及一份关于视力相关生活质量的有效问卷(美国国立眼科研究所视觉功能问卷[NEI-VFQ]-39)。

结果

平均随访10.6年后,平均视力随时间显著下降,最小分辨角对数([logMAR]范围:-0.22至1.3;P=0.009)下降了0.16。此外,与健康对照相比,几乎所有类别中,患者基于NEI-VFQ-39报告的视力相关生活质量较低。与其他诊断实体相比,光学相干断层扫描更常诊断出黄斑萎缩。56%的患者在光学相干断层扫描中记录到黄斑区视网膜色素上皮脱离。与未受影响的对侧眼相比,随时间测量到黄斑中心凹厚度显著变薄(P=0.002)。长期随访中,13只眼(37%)在荧光素血管造影中显示热点数量增加。

结论

本研究表明,cCSC在许多患者中是一种进行性疾病,导致视力逐渐下降,同时报告的视力相关生活质量较低。在决定是否治疗时,对于这个相对年轻且通常仍在职业上活跃的患者群体,应考虑cCSC的进行性本质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfde/5189979/1cd9eb1cdb06/opth-11-039Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfde/5189979/3744e0b888db/opth-11-039Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfde/5189979/1cd9eb1cdb06/opth-11-039Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfde/5189979/3744e0b888db/opth-11-039Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfde/5189979/1cd9eb1cdb06/opth-11-039Fig2.jpg

相似文献

1
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life.慢性中心性浆液性脉络膜视网膜病变:长期随访及与视力相关的生活质量
Clin Ophthalmol. 2016 Dec 20;11:39-46. doi: 10.2147/OPTH.S115685. eCollection 2017.
2
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.慢性中心性浆液性脉络膜视网膜病变患者半剂量光动力疗法与高密度阈下微脉冲激光治疗的比较(PLACE试验):一项随机对照试验的研究方案
Trials. 2015 Sep 21;16:419. doi: 10.1186/s13063-015-0939-z.
3
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变消退后的视力和视网膜形态损害
BMC Ophthalmol. 2019 Jul 25;19(1):160. doi: 10.1186/s12886-019-1171-5.
4
Cystoid macular degeneration in chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变中的黄斑囊样变性
Retina. 2003 Feb;23(1):1-7; quiz 137-8. doi: 10.1097/00006982-200302000-00001.
5
Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变:视力预后的易感因素
Semin Ophthalmol. 2018;33(5):690-699. doi: 10.1080/08820538.2017.1416414. Epub 2017 Dec 18.
6
[Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].[光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变和弥漫性视网膜上皮病变]
J Fr Ophtalmol. 2012 Feb;35(2):82-7. doi: 10.1016/j.jfo.2011.07.005. Epub 2011 Sep 1.
7
Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.低强度/高密度阈下微脉冲二极管激光治疗慢性中心性浆液性脉络膜视网膜病变
Retina. 2015 Mar;35(3):532-6. doi: 10.1097/IAE.0000000000000285.
8
Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.阈下微脉冲黄光激光(577纳米)光凝治疗慢性中心性浆液性脉络膜视网膜病变的短期疗效
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2129-35. doi: 10.1007/s00417-015-2965-7. Epub 2015 Feb 26.
9
Long-term results of low-fluence photodynamic therapy for chronic central serous chorioretinopathy.低能量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的长期疗效
J Fr Ophtalmol. 2015 Oct;38(8):709-16. doi: 10.1016/j.jfo.2015.02.007. Epub 2015 Sep 4.
10
Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).经扫频源光学相干断层扫描血管造影(SS OCTA)诊断的新生血管性和非新生血管性慢性中心性浆液性脉络膜视网膜病变(CSC)的临床评估
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1581-1590. doi: 10.1007/s00417-019-04297-z. Epub 2019 Apr 29.

引用本文的文献

1
[Long-term outcome after photodynamic therapy of persistent central serous chorioretinopathy].[持续性中心性浆液性脉络膜视网膜病变光动力治疗后的长期预后]
Ophthalmologie. 2025 Aug 23. doi: 10.1007/s00347-025-02311-w.
2
Comparison of microvasculature between neovascular, non-neovascular chronic central serous chorioretinopathy cases and asymptomatic fellow eyes using swept-source optical coherence tomography angiography.使用扫频光学相干断层扫描血管造影术比较新生血管性、非新生血管性慢性中心性浆液性脉络膜视网膜病变病例与无症状对侧眼之间的微血管系统。
Int Ophthalmol. 2025 Jul 18;45(1):297. doi: 10.1007/s10792-025-03673-5.
3
Sleep and mood in central serous chorioretinopathy.

本文引用的文献

1
Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.慢性中心性浆液性脉络膜视网膜病变与年龄相关性黄斑变性相关的遗传变异有关。
Ophthalmology. 2015 Mar;122(3):562-70. doi: 10.1016/j.ophtha.2014.09.026. Epub 2014 Nov 6.
2
Coping flexibility and psychological adjustment to stressful life changes: a meta-analytic review.应对灵活性和心理调整应对压力生活变化:元分析综述。
Psychol Bull. 2014 Nov;140(6):1582-607. doi: 10.1037/a0037913. Epub 2014 Sep 15.
3
Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
中心性浆液性脉络膜视网膜病变中的睡眠与情绪
Eye (Lond). 2025 Jun;39(8):1615-1623. doi: 10.1038/s41433-025-03688-3. Epub 2025 Feb 26.
4
Quantitative Changes in Vascular and Neural Fibers Induced by Subretinal Fluid Excluding the Peripapillary Region in Patients with Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者视网膜下液(不包括视乳头周围区域)诱导的血管和神经纤维的定量变化
Diagnostics (Basel). 2025 Jan 14;15(2):174. doi: 10.3390/diagnostics15020174.
5
Fluorescein angiography patterns and subretinal hyperreflective material predict subthreshold micropulse laser response in chronic central serous chorioretinopathy.荧光素血管造影模式和视网膜下高反射物质预测慢性中心性浆液性脉络膜视网膜病变中阈下微脉冲激光的反应。
BMC Ophthalmol. 2024 Nov 4;24(1):478. doi: 10.1186/s12886-024-03711-3.
6
Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy.导航阈下微脉冲激光与光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的视觉和解剖学评估
Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):405-414. doi: 10.1007/s00417-024-06666-9. Epub 2024 Oct 19.
7
Influencing factors for pediatric eye disorders and health related quality of life: a cross-sectional study in Shanghai, China.儿童眼部疾病的影响因素及健康相关生活质量:中国上海的一项横断面研究。
Front Med (Lausanne). 2024 Jul 30;11:1420848. doi: 10.3389/fmed.2024.1420848. eCollection 2024.
8
Exploring Non-Modifiable and Modifiable Determinants of Vision-Related Quality of Life in Central Serous Chorioretinopathy.探索中心性浆液性脉络膜视网膜病变中与视力相关的生活质量的不可改变和可改变决定因素。
J Clin Med. 2024 Jul 25;13(15):4359. doi: 10.3390/jcm13154359.
9
PREDNISOLONE EYE DROPS AS A POTENTIAL TREATMENT IN NONNEOVASCULAR PACHYCHOROID-RELATED DISEASES.泼尼松龙滴眼液作为一种治疗非新生血管性相关疾病的潜在疗法。
Retina. 2024 Aug 1;44(8):1371-1378. doi: 10.1097/IAE.0000000000004109.
10
Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages.脉络膜中性别类固醇受体的差异表达与不同年龄的中心性浆液性脉络膜视网膜病变的性别流行率一致。
Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):5. doi: 10.1167/iovs.65.8.5.
点状高荧光斑作为中心性浆液性脉络膜视网膜病变和息肉状脉络膜血管病变的一种常见脉络膜病变。
Am J Ophthalmol. 2014 Dec;158(6):1155-1163.e1. doi: 10.1016/j.ajo.2014.08.010. Epub 2014 Aug 12.
4
Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy.常见的补体因子 H 基因突变与中心性浆液性脉络膜视网膜病变的易感性相关。
Ophthalmology. 2014 May;121(5):1067-72. doi: 10.1016/j.ophtha.2013.11.020. Epub 2013 Dec 21.
5
Retinal and choroidal changes observed with 'En face' enhanced-depth imaging OCT in central serous chorioretinopathy.“En face”增强深度成像 OCT 观察到的中心性浆液性脉络膜视网膜病变的视网膜和脉络膜改变。
Br J Ophthalmol. 2013 Sep;97(9):1181-6. doi: 10.1136/bjophthalmol-2012-302974. Epub 2013 Jul 3.
6
Pachychoroid pigment epitheliopathy.脉络膜增厚性色素上皮病变。
Retina. 2013 Sep;33(8):1659-72. doi: 10.1097/IAE.0b013e3182953df4.
7
Central serous chorioretinopathy: update on pathophysiology and treatment.中心性浆液性脉络膜视网膜病变:发病机制和治疗的最新进展。
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.
8
Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema.视觉功能问卷-25 在糖尿病性黄斑水肿患者中的心理测量学验证。
Health Qual Life Outcomes. 2013 Jan 24;11:10. doi: 10.1186/1477-7525-11-10.
9
Central serous chorioretinopathy: a review of epidemiology and pathophysiology.中心性浆液性脉络膜视网膜病变:流行病学和发病机制的综述。
Clin Exp Ophthalmol. 2013 Mar;41(2):201-14. doi: 10.1111/j.1442-9071.2012.02848.x. Epub 2012 Sep 21.
10
Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.单侧活跃性中心性浆液性脉络膜视网膜病变患者双眼脉络膜厚度。
Eye (Lond). 2011 Dec;25(12):1635-40. doi: 10.1038/eye.2011.258. Epub 2011 Oct 21.